Skip to main content

Table 2 Serum AMH levels according to clinical presentation

From: Anti-Müllerian hormone as a marker of steroid and gonadotropin action in the testis of children and adolescents with disorders of the gonadal axis

 

Serum AMH

Clinical sign

Undetectable

Low

Normal

High

Cryptorchidism

Anorchidism (Testicular regression, bilateral gonadectomy)

PMDS - AMH mutation

Primary hypogonadism (testicular dysgenesis syndrome)

Central hypogonadism

Rules out testicular dysgenesis

PMDS - AMHR mutation

--

Micropenis

Fetal testicular regression

Primary hypogonadism

Central hypogonadism

Malformative micropenis

--

Absence of puberty

Testicular regression

Bilateral gonadectomy

Primary hypogonadism

Central hypogonadism

Constitutional delay of puberty

--

Precocious pubertal signs

--

Central Precocious Puberty

Testotoxicosis

Leydig cell tumor

Congenital adrenal hyperplasia

Adrenal androgen-secreting tumors

Exogenous androgen exposure

--

Prepubertal macro-orchidism

--

--

--

McCune-Albright syndrome

Sex-cord stromal tumors

DSD

46,XY Complete gonadal dysgenesis

46,XY Partial gonadal dysgenesis

Sex-chromosome gonadal dysgenesis

Ovotesticular DSD

Androgen synthesis defects

Androgen insensitivity

46,XY Malformative DSD

46,XX male (Testicular DSD)

Androgen synthesis defects

Androgen insensitivity

  1. Serum AMH levels are considered low, normal or high as compared to those expected for age in normal boys
  2. AMH-R AMH receptor, DSD disorders of sex development, PMDS persistent Müllerian duct syndrome